CD4 and Sepsis: In the future, we plan to conduct in-depth experimental investigations to delineate how SHKBP1 contributes to sepsis-induced immune dysregulation and its relationship with cuproptosis (particularly in macrophages and CD4+ T cells), and to carry out prospective clinical studies to evaluate the practical clinical utility of our diagnostic model.